This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Mediclinic International Crecimiento futuro

13.0%

Tasa de crecimiento de los beneficios

14.0%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Healthcare	17.2%
Tasa de crecimiento de los ingresos	4.3%
Rentabilidad financiera futura	7.4%
Cobertura de analistas	Good
Última actualización	n/a

No hay actualizaciones

Previsiones de crecimiento de beneficios e ingresos

OTCPK:ANHG.Y - Estimaciones futuras de los analistas y datos financieros pasados (GBP Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
3/31/2025	3,712	266	326	552	7
3/31/2024	3,593	240	301	523	7
3/31/2023	3,461	209	217	449	7
3/31/2022	3,233	151	375	554	N/A
12/31/2021	3,199	135	321	483	N/A
9/30/2021	3,165	118	266	412	N/A
6/30/2021	3,080	93	183	324	N/A
3/31/2021	2,995	68	99	235	N/A
12/31/2020	2,987	-173	N/A	N/A	N/A
9/30/2020	2,979	-414	133	306	N/A
6/30/2020	3,031	-367	203	381	N/A
3/31/2020	3,083	-320	273	456	N/A
12/31/2019	3,070	-97	N/A	N/A	N/A
9/30/2019	3,057	126	246	443	N/A
6/30/2019	2,995	-12	175	394	N/A
3/31/2019	2,932	-151	104	344	N/A
12/31/2018	2,897	-380	N/A	N/A	N/A
9/30/2018	2,861	-610	23	277	N/A
6/30/2018	2,869	-551	57	311	N/A
3/31/2018	2,876	-492	91	345	N/A
12/31/2017	2,874	-211	N/A	N/A	N/A
9/30/2017	2,871	69	97	350	N/A
6/30/2017	2,810	149	121	364	N/A
3/31/2017	2,749	229	145	377	N/A
12/31/2016	2,565	210	155	375	N/A
9/30/2016	2,380	191	165	373	N/A
6/30/2016	2,244	184	150	347	N/A
3/31/2016	2,107	177	134	320	N/A
12/31/2015	2,080	211	N/A	314	N/A

Ingresos vs. Tasa de ahorro: ANHG.Y's forecast earnings growth (13% per year) is above the savings rate (2%).

Beneficios vs. Mercado: ANHG.Y's earnings (13% per year) are forecast to grow slower than the US market (13.5% per year).

Beneficios de alto crecimiento: ANHG.Y's earnings are forecast to grow, but not significantly.

Ingresos vs. Mercado: ANHG.Y's revenue (4.3% per year) is forecast to grow slower than the US market (7.3% per year).

Ingresos de alto crecimiento: ANHG.Y's revenue (4.3% per year) is forecast to grow slower than 20% per year.

ROE futura: ANHG.Y's Return on Equity is forecast to be low in 3 years time (7.4%).